Gan, H. K., Reardon, D. A., Lassman, A. B., Merrell, R., van den Bent, M., Butowski, N., . . . Kumthekar, P. (2018). Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma. Neuro Oncol.
Styl ChicagoGan, Hui K., et al. "Safety, Pharmacokinetics, and Antitumor Response of Depatuxizumab Mafodotin As Monotherapy or in Combination With Temozolomide in Patients With Glioblastoma." Neuro Oncol 2018.
Citace podle MLAGan, Hui K., et al. "Safety, Pharmacokinetics, and Antitumor Response of Depatuxizumab Mafodotin As Monotherapy or in Combination With Temozolomide in Patients With Glioblastoma." Neuro Oncol 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..